Calumet Specialty Products Partners Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Calumet Specialty Products Partners stock.
View analyst ratings for Calumet Specialty Products Partners or view top-rated stocks.

Wall Street analysts have given Calumet Specialty Products Partners a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Calumet Specialty Products Partners wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Calumet Specialty Products Partners saw a decrease in short interest during the month of May. As of May 28th, there was short interest totaling 74,700 shares, a decrease of 52.5% from the May 13th total of 157,100 shares. Based on an average daily volume of 184,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the company's shares are sold short.
View Calumet Specialty Products Partners' Short Interest.

Calumet Specialty Products Partners is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Calumet Specialty Products Partners.

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) released its quarterly earnings data on Friday, May, 7th. The oil and gas company reported ($1.82) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.85) by $0.97. The oil and gas company had revenue of $600.30 million for the quarter, compared to the consensus estimate of $586.20 million.
View Calumet Specialty Products Partners' earnings history.

Calumet Specialty Products Partners' stock was trading at $2.23 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLMT stock has increased by 218.4% and is now trading at $7.10.
View which stocks have been most impacted by COVID-19.

1 equities research analysts have issued 1-year price targets for Calumet Specialty Products Partners' stock. Their forecasts range from $8.00 to $8.00. On average, they anticipate Calumet Specialty Products Partners' stock price to reach $8.00 in the next year. This suggests a possible upside of 12.7% from the stock's current price.
View analysts' price targets for Calumet Specialty Products Partners or view top-rated stocks among Wall Street analysts.

18 employees have rated Calumet Specialty Products Partners CEO Tim Go on Glassdoor.com. Tim Go has an approval rating of 42% among Calumet Specialty Products Partners' employees. This puts Tim Go in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Calumet Specialty Products Partners include YPF Sociedad Anónima (YPF), PBF Energy (PBF), CVR Energy (CVI), Delek US (DK), Vertex Energy (VTNR), Trecora Resources (TREC), BP Prudhoe Bay Royalty Trust (BPT) and Green Planet Group (GNPG).
View all of CLMT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Calumet Specialty Products Partners investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG), Roper Technologies (ROP) and New Residential Investment (NRZ).

Calumet Specialty Products Partners trades on the NASDAQ under the ticker symbol "CLMT."

Calumet Specialty Products Partners' stock is owned by a number of institutional and retail investors. Top institutional investors include Adams Asset Advisors LLC (4.85%), Knott David M (3.62%), Goldman Sachs Group Inc. (0.62%), Caption Management LLC (0.47%), Windsor Group LTD (0.34%) and Morgan Stanley (0.31%).
View institutional ownership trends for Calumet Specialty Products Partners.

CLMT stock was sold by a variety of institutional investors in the last quarter, including Adams Asset Advisors LLC, Royal Bank of Canada, Citigroup Inc., and UBS Group AG.
View insider buying and selling activity for Calumet Specialty Products Partners or view top insider-selling stocks.

CLMT stock was acquired by a variety of institutional investors in the last quarter, including Caption Management LLC, Knott David M, Goldman Sachs Group Inc., Jane Street Group LLC, Windsor Group LTD, Arrowstreet Capital Limited Partnership, Morgan Stanley, and Valmark Advisers Inc..
View insider buying and selling activity for Calumet Specialty Products Partners or or view top insider-buying stocks.

Shares of CLMT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLMT stock can currently be purchased for approximately $7.10.

Calumet Specialty Products Partners has a market capitalization of $558.60 million and generates $2.27 billion in revenue each year. The oil and gas company earns $-149,000,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis.

Calumet Specialty Products Partners employs 1,400 workers across the globe.

The official website for Calumet Specialty Products Partners is www.calumetspecialty.com.

Calumet Specialty Products Partners is headquartered at 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214.

Calumet Specialty Products Partners' mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The oil and gas company can be reached via phone at (317) 328-5660 or via email at [email protected]